Patrick Fabbio
CIK 1658859 · Chief Financial Officer · last filed 2026-04-03
Patrick Fabbio is a Chief Financial Officer who has filed 19 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for BYSI, was dated Apr 3, 2026. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.00M
4
19
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYSI | Director | — | $1.57 | — | $0 | 2 | 2026-04-03 |
| TARA | Chief Financial Officer | 64,115 | $3.90 | $250.0K | $0 | 8 | 2026-01-27 |
| RFL | CFO & President | 335,175 | $2.24 | $750.8K | $0 | 3 | 2022-12-23 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | CFO | — | — | — | $0 | 6 | 2020-03-04 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-03 | BYSI | Grant (A) | — | $0 | EDGAR |
| 2026-01-27 | TARA | Tax (F) | −3,261 | -$21.8K | EDGAR |
| 2026-01-22 | TARA | Tax (F) | −3,063 | -$17.2K | EDGAR |
| 2026-01-21 | TARA | Grant (A) | +28,000 | $0 | EDGAR |
| 2025-04-23 | BYSI | Grant (A) | — | $0 | EDGAR |
| 2025-03-28 | TARA | — | — | $0 | EDGAR |
| 2025-01-28 | TARA | Grant (A) | +23,500 | $0 | EDGAR |
| 2025-01-23 | TARA | Tax (F) | −3,061 | -$14.6K | EDGAR |
| 2024-01-23 | TARA | Grant (A) | +22,000 | $0 | EDGAR |
| 2023-01-30 | TARA | Grant (A) | — | $0 | EDGAR |